Filing Details

Accession Number:
0001483813-13-000092
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-14 18:11:10
Reporting Period:
2013-08-12
Filing Date:
2013-08-14
Accepted Time:
2013-08-14 18:11:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1159036 Halozyme Therapeutics Inc HALO Biological Products, (No Disgnostic Substances) (2836) 880488686
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206977 E Kathryn Falberg 11388 Sorrento Valley Road
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-12 50,000 $6.72 230,000 No 4 P Direct
Common Stock Acquisiton 2013-08-14 50,000 $6.91 280,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $6.605 to $6.84. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares purchased at each separate price.
  2. This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $6.85 to $6.95. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares purchased at each separate price.